MODIFICATIONS OF CUPREDOXIN DERIVED PEPTIDES AND METHODS OF USE THEREOF
    2.
    发明申请
    MODIFICATIONS OF CUPREDOXIN DERIVED PEPTIDES AND METHODS OF USE THEREOF 有权
    铜绿假单胞菌肽的修饰及其使用方法

    公开(公告)号:US20100267608A1

    公开(公告)日:2010-10-21

    申请号:US11853497

    申请日:2007-09-11

    摘要: The present invention provides modified cupredoxin derived peptides with pharmacologic activity that have improved pharmacokinetic properties, and methods to use them to treat mammals suffering from various conditions related to the pharmacologic activities. Modifications of the cupredoxin derived peptides include amino acid sequence variants and structural derivations that increase the plasma half-life of the peptide, increase the specific activity of the pharmacologic activity, decrease immunogenicity, and decrease the biotransformation of the peptides. The modified cupredoxin derived peptides can be used in methods to treat mammals for cancer, conditions related to inappropriate angiogenesis, viral and bacterial infections, and specifically HIV and malaria, conditions related to ephrin signaling, and to deliver cargo compounds, including diagnostic compounds, to cancer cells.

    摘要翻译: 本发明提供具有改善的药代动力学性质的具有药理学活性的改良的铜绿假单胞菌衍生肽以及使用它们治疗患有与药理学活性相关的各种病症的哺乳动物的方法。 铜氧还蛋白衍生肽的修饰包括增加肽的血浆半衰期的氨基酸序列变体和结构衍生物,增加药物活性的比活性,降低免疫原性并降低肽的生物转化。 改良的氧还蛋白衍生肽可用于治疗哺乳动物癌症的方法,与不适当的血管生成,病毒和细菌感染以及特别是HIV和疟疾有关的病症,与ephrin信号传导相关的病症,以及将包括诊断化合物在内的货物化合物递送至 癌细胞。

    COMPOSITIONS AND METHODS TO PREVENT CANCER WITH CUPREDOXINS
    7.
    发明申请
    COMPOSITIONS AND METHODS TO PREVENT CANCER WITH CUPREDOXINS 审中-公开
    用于预防癌症的组合物和方法

    公开(公告)号:US20120302509A1

    公开(公告)日:2012-11-29

    申请号:US13555376

    申请日:2012-07-23

    摘要: The present invention relates to compositions comprising peptides that may be variants, derivatives and structural equivalents of cupredoxins that inhibit the development of premalignant lesions in mammalian cells, tissues and animals. Specifically, these compositions may comprise azurin from Pseudomonas aeruginosa, and/or the 50-77 residue region of azurin (p28). The present invention further relates to compositions that may comprise cupredoxin(s), and/or variants, derivatives or structural equivalents of cupredoxins, that retain the ability to inhibit the development of premalignant lesions in mammalian cells, tissues or animals. These compositions may be peptides or pharmaceutical compositions, among others. The compositions of the invention may be used to prevent the development of premalignant lesions in mammalian cells, tissues and animals, and thus prevent cancer.

    摘要翻译: 本发明涉及包含肽的组合物,其可以是抑制哺乳动物细胞,组织和动物中恶化前病变发展的铜氧还蛋白的变体,衍生物和结构等同物。 具体地,这些组合物可以包含来自绿脓假单胞菌的吖啶素和/或吖啶的50-77残基区域(p28)。 本发明还涉及可包含铜氧还蛋白的组合物和/或氧还蛋白的变体,衍生物或结构等同物,其保留抑制哺乳动物细胞,组织或动物中恶化前病变发展的能力。 这些组合物可以是肽或药物组合物等。 本发明的组合物可用于预防哺乳动物细胞,组织和动物中癌前病变的发展,从而预防癌症。